NBY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. NovaBay Pharmaceuticals Inc's cash to debt ratio for the quarter that ended in Mar. 2016 was 0.47.
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, NovaBay Pharmaceuticals Inc couldn't pay off its debt using the cash in hand for the quarter that ended in Mar. 2016.
During the past 12 years, NovaBay Pharmaceuticals Inc's highest Cash to Debt Ratio was No Debt. The lowest was 0.47. And the median was N/A.
This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Current Portion of Long-Term Debt and Long-Term Debt. This ratio measures the financial strength of a company. This ratio is updated quarterly.
NovaBay Pharmaceuticals Inc's Cash to Debt Ratio for the fiscal year that ended in Dec. 2014 is calculated as:
NovaBay Pharmaceuticals Inc had no debt.
NovaBay Pharmaceuticals Inc's Cash to Debt Ratio for the quarter that ended in Mar. 2016 is calculated as:
|Cash to Debt Ratio||=||Cash, Cash Equivalents, Marketable Securities||/||Total Debt|
|=||Cash, Cash Equivalents, Marketable Securities||/||(Short-Term Debt||+||Long-Term Debt)|
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
NovaBay Pharmaceuticals Inc Annual Data
|cash2debt||No Debt||27.87||13.67||23.67||120.81||No Debt||No Debt||No Debt||No Debt||1.44|
NovaBay Pharmaceuticals Inc Quarterly Data
|cash2debt||No Debt||No Debt||No Debt||No Debt||No Debt||No Debt||No Debt||No Debt||1.44||0.47|